News
Acadia Pharmaceuticals Presents New DAYBUE Clinical Data At The 2024 American Academy Of Neurology Annual Meeting
17 Apr 24
Biotech, News, General
Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals
10 Apr 24
Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on ACADIA Pharmaceuticals, Maintains $37 Price Target
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Needham Reiterates Buy on ACADIA Pharmaceuticals, Maintains $32 Price Target
9 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Expert Ratings For ACADIA Pharmaceuticals
25 Mar 24
Analyst Ratings
JP Morgan Maintains Overweight on ACADIA Pharmaceuticals, Lowers Price Target to $25
25 Mar 24
News, Price Target, Analyst Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
19 Mar 24
Options
Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Lowers Price Target to $30
13 Mar 24
News, Price Target, Analyst Ratings
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
12 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $30.19
12 Mar 24
News, Price Target, Analyst Ratings
RBC Capital Maintains Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $30
12 Mar 24
News, Price Target, Analyst Ratings
Cantor Fitzgerald Maintains Overweight on ACADIA Pharmaceuticals, Lowers Price Target to $37
12 Mar 24
News, Price Target, Analyst Ratings
Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
12 Mar 24
News, Price Target, Markets, Analyst Ratings, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Mar 24
Movers
Oppenheimer Maintains Perform on ACADIA Pharmaceuticals, Lowers Price Target to $19
12 Mar 24
News, Price Target, Analyst Ratings
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
12 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Baird Maintains Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $31
12 Mar 24
News, Price Target, Analyst Ratings
B of A Securities Maintains Neutral on ACADIA Pharmaceuticals, Lowers Price Target to $30
12 Mar 24
News, Price Target, Analyst Ratings
Trial Setback For Acadia Pharmaceuticals' Late-Stage Schizophrenia Trial: Details
12 Mar 24
Biotech, Equities, News, Health Care, Movers, Trading Ideas, General
Canaccord Genuity Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $33
12 Mar 24
News, Price Target, Analyst Ratings
Press releases
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
24 Apr 24
Press Releases
Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
22 Apr 24
Press Releases
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 Apr 24
Press Releases
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
17 Apr 24
Press Releases
Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development
2 Apr 24
Press Releases
Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
1 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
11 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
3 Mar 24
Press Releases
Acadia Pharmaceuticals to Participate in TD Cowen's 44th Annual Health Care Conference on March 6, 2024
29 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
28 Feb 24
News, Legal, Press Releases
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview
27 Feb 24
Press Releases
ACADIA Pharmaceuticals Inc. Investors: Please contact the Portnoy Law Firm to recover your losses
22 Feb 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
22 Feb 24
News, Legal, Press Releases
Tonix Pharmaceuticals Pioneering in the shifting landscape of the Dynamic CNS Therapeutics Market
13 Feb 24
Acadia Announces Additions to Executive Team
30 Jan 24
Press Releases